Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 4 Results

  1. 1
    375003

    WHO guidelines for the treatment of Chlamydia trachomatis.

    World Health Organization [WHO]

    Geneva, Switzerland, WHO, 2016. [56] p.

    Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated treatment recommendations for common infections caused by C. trachomatis based on the most recent evidence; they form one of several modules of guidelines for specific STIs. It is strongly recommended that countries take updated global guidance into account as they establish standardized national protocols, adapting this guidance to the local epidemiological situation and antimicrobial susceptibility data. The objectives of these guidelines are: to provide evidence-based guidance on treatment of infection with C. trachomatis; and to support countries to update their national guidelines for treatment of chlamydial infection.
    Add to my documents.
  2. 2
    375002

    WHO guidelines for the treatment of Treponema pallidum (syphilis).

    World Health Organization [WHO]

    Geneva, Switzerland, WHO, 2016. [60] p.

    Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. These guidelines provide updated treatment recommendations for treatment of Treponema pallidum (syphilis) based on the most recent evidence. They form one of several modules of guidelines for specific STIs. It is strongly recommended that countries take updated global guidance into account as they establish standardized national protocols and adapt it to the local epidemiological situation and antimicrobial susceptibility data. The objectives of these guidelines are: to provide evidence-based guidance on treatment of infection with Treponema pallidum; and to support countries to update their national guidelines for treatment of Treponema pallidum.
    Add to my documents.
  3. 3
    375001

    WHO guidelines for the treatment of Neisseria gonorrhoeae.

    World Health Organization [WHO]

    Geneva, Switzerland, WHO, 2016. [64] p.

    Since the publication of the WHO Guidelines for the management of sexually transmitted infections in 2003, changes in the epidemiology of STIs and advancements in prevention, diagnosis and treatment necessitate changes in STI management. There is an urgent need to update treatment recommendations for gonococcal infections to respond to changing antimicrobial resistance (AMR) patterns of N. gonorrhoeae. High-level resistance to previously recommended quinolones is widespread and decreased susceptibility to the extended-spectrum (third-generation) cephalosporins, another recommended first-line treatment in the 2003 guidelines, is increasing and several countries have reported treatment failures. These guidelines for the treatment of common infections caused by N. gonorrhoeae form one of several modules of guidelines for specific STIs. It is strongly recommended that countries take updated global guidance into account as they establish standardized national protocols, adapting this guidance to the local epidemiological situation and antimicrobial susceptibility data. The objectives of these guidelines are: to provide evidence-based guidance on treatment of infection with N. gonorrhoeae; and to support countries to update their national guidelines for treatment of gonococcal infection.
    Add to my documents.
  4. 4
    192145

    HIV / AIDS epidemiological surveillance update for the WHO African Region, 2002.

    World Health Organization [WHO]. Regional Office for Africa

    Harare, Zimbabwe, WHO, Regional Office for Africa, 2003 Sep. xi, 56 p.

    A detailed review of the HIV/AIDS situation and surveillance practices in the 46 countries of the WHO African Region was published in 20001. The current report presents an update of the HIV/AIDS epidemic in the WHO African Region based predominantly on data from country surveillance reports produced for 2001 and 2002. Additional data included in the report are from population-based surveys and selected research studies. The report does not provide HIV/AIDS estimates, but presents a synthesis and analysis of data generated by existing surveillance systems. The focus of the report is on the assessment of trends in HIV prevalence within countries and sub-regions. In addition, data are presented on the current situation and trends in sexually transmitted infections and sexual behaviour, which are both part of comprehensive HIV surveillance systems. The report is comprised of two parts. Part I presents a comprehensive review of the most recent data in the WHO African Region as a whole. It also provides data by sub-region with the exception of the Indian Ocean sub-region where no data for the last two years were available. Part II is published separately and consists of country profiles that include brief descriptions of the most recent data and trends, with a focus on young people. (excerpt)
    Add to my documents.